Enzyme formulation for reducing histamine intolerance
OwnerThea Fournierinventor
Life of this patent
Estimating the term…
Abstract
Disclosed is a formulation of the following enzymes: Alpha-galactosidase, Alpha amylase, Beta Glucanase, Lactase, BioCor DPP=IV (Proprietary blend) and Pectinase, which has been found to be effective in treating histamine intolerant people, and causing a significant improvement in a wide variety of pathologies and symptoms, including, but not limited to: inflammation, pruritus, urticaria, hypotension, tachycardia, fatigue, migraines, conjunctivitis, incontinence, nasal congestion, panic attacks, acid reflux, depression and angioedema.
Claims6
A method for treating one or more histamine-related symptoms selected from pruritus, fatigue, nasal congestion, panic attacks and angioedema in a subject in need, the method comprising administering to the subject in need a formulation including:
- Alpha-galactosidase, Alpha amylase, Beta Glucanase, Lactase, DPP-IV and Pectinase thereby treating said one or more histamine-related symptoms.
Dependencies are inferred from the claim text.